Australia says it won’t raise drug prices after Trump’s 100% tariff on pharmaceuticals imported into US

Australian Health Minister Mark Butler says the government will not remove price protections on medications despite pressure from pharmaceutical companies and the Trump administration. Trump imposed a 100% tariff on branded pharmaceuticals imported into the U.S. overnight, a move designed to force drug manufacturers to accept lower pricing deals or shift production domestically. Butler stated explicitly that Australia is "not negotiating" on consumer price protections for common medications. The dispute reflects a clash between the Trump administration's push to lower drug costs through tariffs and Australia's commitment to its existing pharmaceutical pricing system. The tariff could affect Australian pharmaceutical exports to the U.S. market while testing whether other nations will maintain their own drug-pricing policies under American trade pressure.